AN EVALUATION OF ALZHEIMER DISEASE (AD) AMONG ADULTS AGED 65+: BURDENS AND PATHWAYS

Authors

  • Bruno Onyinye Umunakwe Applied Health, Brigham Young University – Idaho, United States
  • Adaeze Annthereeza Okoroji Social care, Health and wellbeing, University of Greater Manchester, United Kingdom

Keywords:

Alzheimer’s Disease, Dementia. Cognitive decline. Aging, Neurodegenerative disorders

Abstract

Alzheimer’s Disease (AD) is a progressive neurodegenerative disorder prevalent among adults aged 65 and older, contributing to significant cognitive, physical, and emotional burdens. With millions of global cases and projections, AD poses a critical public health challenge to the aging population. This study aims at investigating burdens and pathways of AD among adults aged 65+ Qualitative approach was employed to analyse AD’s stages, symptoms, risk factors, and associated burdens. Findings reveal that AD progresses through distinct phases - preclinical, mild cognitive impairment, and dementia stages marked by memory loss, behavioural changes, and functional decline. Key risk factors such as age, genetic predisposition (e.g., APOE ε4 allele), cardiovascular diseases, and lifestyle factors like smoking and obesity contribute to AD within adults aged 65+. AD leads to cognitive deterioration, physical disabilities, and emotional distress, while caregivers face psychological and economic strains. The study concludes that AD has no cure, but it can be managed through lifestyle modifications (e.g., exercise, social engagement), and caregiver support. It is recommended that promoting brain-healthy behaviours, early diagnosis, and multidisciplinary care approaches can improve quality of life for aging populations

References

2024 Alzheimer’s disease facts and figures. Alzheimer’s Dement. 2024 May; 20(5):3708-3821. https://doi.org/10.1002/alz.13809.

Aliaskar, A.G. (2024). Improving mental health and quality of life of aging population. Journal of Awareness, 9(1), 191-200. https://doi.org/10.26809/joa.2285.

Alzheimer Association Report. (2024). 2024 Alzheimer’s disease facts and figures. Alzheimer’s and Dementia: The Journal of The Alzheimer Association, 20, 3708-3821. https://doi.org/10.1002/alz.13809.

Alzheimer Association. (2024). 2024 Alzheimer’s disease Facts and Figures. Retrieved From: https://www.alz.org/media/Documents/alzheimers-facts-and-figures.pdf.

Alzheimer Association. (2024). Stages of Alzheimer’s. Retrieved From: https://www.alz.org/alzheimers-dementia/stages.

Alzheimer Society. (2019). the psychological and emotional impact of dementia. Accessed From: https://www.alzheimers.org.uk/get-support/help-dementia-care/understanding-supporting-person-dementia-psychological-emotional-impact#:~:text=Emotional%20effects,distant%20or%20uninterested%20in%20things.

Alzheimer’s Association. (2024). Stages of Alzheimer’s. Retrieved From: https://www.alz.org/alzheimers-dementia/stages.

Alzheimer’s Association. (2025). Treatments for Behavior. Accessed From: https://www.alz.org/alzheimers-dementia/treatments/treatments-for-behavior.

Alzheimer’s disease. Accessed From: https://medlineplus.gov/alzheimersdisease.html.

Alzheimer's Association. (2024). Treatments for Alzheimer's. Accessed From: https://www.alz.org/alzheimers-dementia/treatments.

Bellenguez, C. & Lmabert, J.C. (2022). New insights into the genetic etiology of Alzheimer’s disease and related dementias. Nature Genetics, 54, pp.412-436. https://doi.org/10.1038/s41588-022-01024-z.

Boucher, L. (2024). 1906: The dawn of Alzheimer’s disease. September 26, 2024. Retrieved from: https://www.nature.com/articles/d41586-024-02881-w.

Breijyeh, Z, & Karaman, R. (2020). Comprehensive Review on Alzheimer's disease: Causes and Treatment. Molecules, 25(24), 1-12. https://doi.org/10.3390/molecules25245789.

Ciciora, D., Vásquez, E., Valachovic, E., Hou, L., Zheng, Y., Xu, H., Jiang, X., Huang, K., Gabriel, P.K., Hong-Wen Deng, Gallant, P.M. & Zhang, K. (2024). Social and Behavior Factors of Alzheimer's disease and Related Dementias: A National Study in the U.S. American Journal of Preventive Medicine, 66(4), 573-581. https://doi.org/10.1016/j.amepre.2023.11.017.

Cleveland Clinic. (2022). Alzheimer’s disease. Retrieved From: https://my.clevelandclinic.org/health/diseases/9164-alzheimers-disease.

Ellis, L. (2024). Mental Health in Older Adults: Challenges and Strategies for Improvement. Journal on Mental Health Aging, 8(6), 240-245.

Ellis, M.E. (2024). What Are the Stages of Alzheimer’s Disease? Updated on: March 28, 2024. Accessed From: https://www.healthline.com/health/stages-progression-alzheimers#stage-2.

George, M. & Bassett, E. (2022). Prevalence of Alzheimer’s disease in Adults in the United States. Accessed From: https://ballardbrief.byu.edu/issue-briefs/prevalence-of-alzheimers-disease-in-adults-in-the-united-states.

Jiwtode, U., Chakole, S. & Bhatt, N. (2021). Alzheimer’s disease: History, Stages, Diagnosis and Its Future. Journal of Pharmaceutical Research International, 33(39A), pp. 41-45. https://doi.org/10.9734/jpri/2021/v33i39A32139.

Johns Hopkins Medicine. (2023). Stages of Alzheimer's disease. Accessed From: https://www.hopkinsmedicine.org/health/conditions-and-diseases/alzheimers-disease/stages-of-alzheimer-disease.

Kindratt, B.T., Zahodne, B.L., Ajrouch, J.K., & Dallo, J. F. (2024). Modifable Risk Factors for Alzheimer’s disease and Related Dementias among Middle Eastern and North African Immigrants to the United States. Innovation in Aging, 8:igae025, 1-9. https://doi.org/10.1093/geroni/igae025.

Kumar, A., Sidhu, J., Lui, F., & Tsao, W.J. (2024). Alzheimer Disease. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. [Updated 2024 Feb. 12]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK499922/.

Lanctota, L.K., Amatniek, J., Ancoli-Israel, S., Arnold, E.S., Ballard, C., Cohen-Mansfield, J., Ismail, Z., Lyketsos, C., Miller, S.D., Musiek, E., Osorio, S.R., Rosenberg, B.P., Satlin, A., Steffens, D., Tariot, P., Bain, J.L., Carrillo, C.M., Hendrix, A.J., Jurgens, H. & Boot, B. (2017). Neuropsychiatric signs and symptoms of Alzheimer’s disease: New treatment paradigms. Alzheimer’s & Dementia: Translational Research & Clinical Interventions, 3, 440-449. http://dx.doi.org/10.1016/j.trci.2017.07.001.

Leblhuber, F., Steiner, K., Schuetz, B., Fuchs, D., & Gostner, J.M. (2018). Probiotic Supplementation in Patients with Alzheimer’s Dementia - An Explorative Intervention Study. Current Alzheimer Research, 15(12), 1106-1113. https://doi.org/10.2174/1389200219666180813144834.

Lekhan, E.S. (2024). Alzheimer Disease. Retrieved From: https://emedicine.medscape.com/article/1134817-overview?form=fpf.

Li, X., Feng, X., Sun, X., Hou, N., Han, F. & Liu, Y. (2022). Global, regional, and national burden of Alzheimer’s disease and other dementias, 1990–2019. Frontiers in Aging Neuroscience, 14:937486, 1-17. doi: 10.3389/fnagi.2022.937486.

Liu, Y., Tan, Y., Zhang, Z., Yi, M., Zhu, L., & Peng, W. (2024). The interaction between ageing and Alzheimer's disease: insights from the hallmarks of ageing. Translational Neurodegeneration, 13(7), 1-17. https://doi.org/10.1186/s40035-024-00397-x.

Long, S., Benoist, C., Weidner, W. (2023). World Alzheimer Report 2023: Reducing dementia risk: never too early, never too late. London, England: Alzheimer’s disease International.

MacGill, M. (2024). What to know about Alzheimer’s disease. Retrieved From: https://www.medicalnewstoday.com/articles/159442.

Maurelli, M., Chiricozzi, A., Peris, K., Gisondi, P. & Girolomoni, G. (2023). Atopic Dermatitis in the Elderly Population. Acta Derm Venereologica, 103: adv13363, 1-13. https://doi.org/10.2340/actadv.v103.13363.

MayoClinic. (2023). Alzheimer’s stages: How the disease progresses. [Update June, 7]. Retrieved From: https://www.mayoclinic.org/diseases-conditions/alzheimers-disease/in-depth/alzheimers-stages/art-20048448.

Megan. (2021). Three Aspects of Health and Healing: The Biopsychosocial Model in Medicine. Updated on: October 10, 2021. Retrieved From: https://surgery.wustl.edu/three-aspects-of-health-and-healing-the-biopsychosocial-model/.

National Health Service (NHS) – England. (2024). Treatment-Alzheimer’s disease. Accessed From: https://www.nhs.uk/conditions/alzheimers-disease/treatment/.

National Institute on Aging. (2023). Preventing Alzheimer’s Disease: What Do We Know? Accessed From: https://www.nia.nih.gov/health/alzheimers-and-dementia/preventing-alzheimers-disease-what-do-we-know.

Nichols, H. (2024). What are the stages of Alzheimer's disease? [Update 2024 April, 15). Retrieved From: https://www.medicalnewstoday.com/articles/315123.

Nitrini, R. (2023). The past, present and future of Alzheimer’s disease–part1: the past. Arquivos de Neuro-Psiquiatria, 81(12), 1070-1076. https://doi.org/10.1055/s-0043-1777722.

Pless, A., Ware, D., Saggu, S., Rehman, H., Morgan, J. & Wang, Q. (2023). Understanding neuropsychiatric symptoms in Alzheimer’s disease: challenges and advances in diagnosis and treatment. Frontiers in Neuroscience, 17:1263771, 1-13. http://dx.doi.org/10.3389/fnins.2023.1263771.

Roberts, A. (2023). The biopsychosocial model: Its use and abuse. Medicine, Health Care and Philosophy, 26, 367–384. https://doi.org/10.1007/s11019-023-10150-2.

Silva, M.V.F., Loures, C.d.M.G., Alves, L.C.V. de Souza, C.L., Borges, G.B.K. & Carvalho, G.D.M. (2019). Alzheimer’s disease: risk factors and potentially protective measures. Journal of Biomedical Science, 26(33), 1-15. https://doi.org/10.1186/s12929-019-0524-y.

Syed, S., Syed, S. & Bhardwaj, K. (2020). The role of the bio-psychosocial model in public health. The Journal of Medical Research, 6(5), 252-254.

Taukeni, G.S. (2020). Biopsychosocial Model of Health. Psychology and Psychiatry, 4(1), 1-2.

World Health Organisation. (WHO). (2023). Dementia. [Updated March, 15). Retrieved From: https://www.who.int/news-room/fact-sheets/detail/dementia.

Zhang, J. (2022). Qualitative Systematic Review in Applied Linguistics: A Synthesis. International. Journal of Language and Literary Studies, 5(1), 156-174. http://doi.org/10.36892/ijlls.v5i1.1208.

Zhang, J., Zhang, Y., Wang, J., Xia, Y., Zhang, J. & Chen, L. (2024). Recent advances in Alzheimer’s disease: mechanisms, clinical trials and new drug development strategies. Signal Transduction and Targeted Therapy, 9(211), 1-35. https://doi.org/10.1038/s41392-024-01911-3.

Downloads

Published

2025-04-14

How to Cite

Bruno, O. U., & Okoroji, A. A. (2025). AN EVALUATION OF ALZHEIMER DISEASE (AD) AMONG ADULTS AGED 65+: BURDENS AND PATHWAYS. Medical and Health Sciences European Journal, 9(2), 154–168. Retrieved from https://aspjournals.org/Journals/index.php/mhsej/article/view/1086

Issue

Section

Articles

Similar Articles

1 2 > >> 

You may also start an advanced similarity search for this article.